Regeneron Pharmaceuticals has agreed to acquire nearly all of 23andMe’s assets for $256 million, including its genetic data, following a bankruptcy auction. The deal still needs to be approved by the ...
Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results